Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (231-240 of 509) with videos related to

Pageof 51
Sort By:
Plos One|November 12, 2016
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-AnalysisHeidi Storgaard, Lise L Gluud, Cathy Bennett, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 10, 2023
Glucose variability in maintenance hemodialysis patients with type 2 diabetes: Comparison of dialysis and nondialysis daysTobias Bomholt, Marianne Rix, Thomas Almdal, et al.
Diabetologia|February 23, 2008
Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetesP V Højberg, M Zander, T Vilsbøll, et al.
Acta Psychiatrica Scandinavica|August 29, 2017
'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' responseB H Ebdrup, P L Ishøy, B Fagerlund, et al.
Trials|June 5, 2016
Shared care management of patients with type 2 diabetes across the primary and secondary healthcare sectors: study protocol for a randomised controlled trialLene Munch, Birgitte Bennich, Anne B Arreskov, et al.
Diabetes, Obesity & Metabolism|July 21, 2020
Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitisLise Gether, Jacob P Thyssen, Mette Gyldenløve, et al.
Diabetology & Metabolic Syndrome|July 25, 2017
Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative reviewBirgitte B Bennich, Michael E Røder, Dorthe Overgaard, et al.
Journal of Clinical Pharmacology|July 31, 2015
Semimechanistic model describing gastric emptying and glucose absorption in healthy subjects and patients with type 2 diabetesOskar Alskär, Jonatan I Bagger, Rikke M Røge, et al.
European Journal of Endocrinology|December 22, 2023
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide cohort studyLine Davidsen, Morten H Jensen, Mathias E Cook, et al.
Acta Psychiatrica Scandinavica|March 6, 2017
No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophreniaP L Ishøy, B Fagerlund, B V Broberg, et al.
Pageof 51

Showing results (231-240 of 509) with videos related to

Sort By:
Pageof 51
Plos One|November 12, 2016
Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-AnalysisHeidi Storgaard, Lise L Gluud, Cathy Bennett, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 10, 2023
Glucose variability in maintenance hemodialysis patients with type 2 diabetes: Comparison of dialysis and nondialysis daysTobias Bomholt, Marianne Rix, Thomas Almdal, et al.
Diabetologia|February 23, 2008
Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetesP V Højberg, M Zander, T Vilsbøll, et al.
Acta Psychiatrica Scandinavica|August 29, 2017
'No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia': authors' responseB H Ebdrup, P L Ishøy, B Fagerlund, et al.
Trials|June 5, 2016
Shared care management of patients with type 2 diabetes across the primary and secondary healthcare sectors: study protocol for a randomised controlled trialLene Munch, Birgitte Bennich, Anne B Arreskov, et al.
Diabetes, Obesity & Metabolism|July 21, 2020
Normal insulin sensitivity, glucose tolerance, gut incretin and pancreatic hormone responses in adults with atopic dermatitisLise Gether, Jacob P Thyssen, Mette Gyldenløve, et al.
Diabetology & Metabolic Syndrome|July 25, 2017
Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative reviewBirgitte B Bennich, Michael E Røder, Dorthe Overgaard, et al.
Journal of Clinical Pharmacology|July 31, 2015
Semimechanistic model describing gastric emptying and glucose absorption in healthy subjects and patients with type 2 diabetesOskar Alskär, Jonatan I Bagger, Rikke M Røge, et al.
European Journal of Endocrinology|December 22, 2023
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide cohort studyLine Davidsen, Morten H Jensen, Mathias E Cook, et al.
Acta Psychiatrica Scandinavica|March 6, 2017
No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophreniaP L Ishøy, B Fagerlund, B V Broberg, et al.
Pageof 51